UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,637 | -71.0% | 14,700 | -2.0% | 0.00% | -75.0% |
| Q4 2022 | $340,050 | -47.9% | 15,000 | -56.9% | 0.00% | -42.9% |
| Q3 2022 | $652,848 | -17.9% | 34,800 | -20.9% | 0.01% | 0.0% |
| Q1 2022 | $795,000 | +86.2% | 44,000 | +113.6% | 0.01% | +133.3% |
| Q4 2021 | $427,000 | -1.8% | 20,600 | +51.5% | 0.00% | -25.0% |
| Q3 2021 | $435,000 | +75.4% | 13,600 | +147.3% | 0.00% | +33.3% |
| Q2 2020 | $248,000 | -22.0% | 5,500 | -17.9% | 0.00% | -25.0% |
| Q1 2020 | $318,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
| Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
| Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
| Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
| Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
| P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
| Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
| Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
| Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |